885270-74-6 Usage
General Description
8-Bromo-2H-chromene-3-carboxylic acid is a compound with the molecular formula C10H6BrO4. It is a derivative of 2H-chromene, which is a class of organic compounds with a benzopyran skeleton. 8-Bromo-2H-chromene-3-carboxylic acid contains a carboxylic acid group and a bromine atom attached to the chromene ring. It is used in organic synthesis as a starting material for the preparation of various pharmaceutical and agrochemical intermediates. Additionally, it has been investigated for its potential biological activities, including its antimicrobial and anti-inflammatory properties. 8-Bromo-2H-chromene-3-carboxylic acid is also a valuable building block for the development of new chemical compounds with potential applications in medicine and agriculture.
Check Digit Verification of cas no
The CAS Registry Mumber 885270-74-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,8,5,2,7 and 0 respectively; the second part has 2 digits, 7 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 885270-74:
(8*8)+(7*8)+(6*5)+(5*2)+(4*7)+(3*0)+(2*7)+(1*4)=206
206 % 10 = 6
So 885270-74-6 is a valid CAS Registry Number.
885270-74-6Relevant articles and documents
NEW ANTHELMINTIC COMPOUNDS
-
, (2020/05/28)
The present invention relates to novel compounds of general formula (I) with A being A1 or A2, and in which T, X, Y, Ro, R1, R10 and R11 are as defined herein, methods of preparing said compounds, intermediate compounds useful for preparing said compounds, pharmaceutical compositions and combinations comprising said compounds and the use of said compounds for the treatment, control and/or prevention of diseases, in particular of helminth infections, as a sole agent or in combination with other active ingredients.
SPIROAMINOOXAZOLINE ANALOGUES AS ALPHA2C ADRENERGIC RECEPTOR MODULATORS
-
Page/Page column 88, (2010/04/28)
In its many embodiments, the present invention provides a novel class of spiroaminooxazoline analogues as modulators of α2C adrenergic receptor, methods of preparing such compounds, pharmaceutical compositions containing one or more such compounds, methods of preparing pharmaceutical formulations comprising one or more such compounds, and methods of treatment, prevention, inhibition, or amelioration of one or more conditions associated with the α2C adrenergic receptors using such compounds or pharmaceutical compositions.
